期刊文献+

经颈内静脉肝内门体分流术治疗肝硬化食道静脉曲张出血的研究 被引量:3

Study of transjugular intrahepatic portosystemic shunt(TIPS) in esophageal varix with hepatic cirrhosis
下载PDF
导出
摘要 目的探讨经颈内静脉肝内门体分流术(TIPS)对肝硬化食道静脉曲张出血患者的疗效以及术后并发症发生的原因及处理方法。方法对2003年5月至2008年5月45例肝硬化食道静脉曲张出血患者病情稳定后进行择期TIPS手术,于左肝静脉与门静脉主干之间分别置入100mm×10mm或100mm×8mm金属支架,对胃冠状静脉采取弹簧圈栓塞,术后观察患者食道胃底静脉曲张程度。结果本组45例肝硬化食管胃底静脉曲张的治愈率为86.7%,好转率为13.3%,有效率为100%。结论TIPS联合胃冠状静脉栓塞作为一种新的对肝硬化食管胃底静脉曲张的治疗方法,安全性高,并发症少,复发率低,疗效确切。 Objective To discuss the effect of transjugular intrahepatic portosystemic shunt(TIPS) in esophageal varix with hepatic cirrhosis, the causes and management of the postoperative complications. Methods TIPS was performed on 45 patients with esophageal varix with hepatic cirrhosis after stable bleeding from May 2003 to May 2008. Metal stents, 100mm×10mm or 100min×8mm, were placed between left hepatic -vein and portal vein,and vena coronaria ventriculi was embolized by circlip ring. The degrees of the various veins were observed after operation. Results The recovery rate,improvement rate and the effect rate were 86.7 %, 13.3% and 100% respectively. Conclusion TIPS combined with vena coronaria venous embolism,a new method in esophageal varix with hepatic cirrhosis,has such fortes as high safety,little complications,low recurrence rate and certain therapeutic effects.
出处 《重庆医学》 CAS CSCD 北大核心 2009年第17期2211-2212,共2页 Chongqing medicine
关键词 经颈内静脉肝内门体分流术 肝硬化 食管胃底静脉曲张 transjugular intrahepatic portosystemic shunt hepatic cirrhosis esophageal and fundus varix
  • 相关文献

参考文献4

二级参考文献23

  • 1陆星华,张泰昌.食管胃静脉曲张内镜下诊断和治疗规范试行方案(2003年)[J].中华消化内镜杂志,2004,21(3):149-151. 被引量:429
  • 2Barange K,Peron JM,Imani K,et al.Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices[J].Hepatology,1999; 30:1139.
  • 3Azoulay D,Castaing D,Majno P,et al.Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis[J].J Hepatol,2001;35:590.
  • 4Rosado B,Kamath PS.Transjugular intrahepatic portosystemic shunts:an update[J].Liver Transpl,2003;9(3):207.
  • 5R ossle M,Ochs A,Gulberg V,et al.A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites[J].N Engl J Med,2000;342:1701.
  • 6Chalasanin ML,Strauss RM,Boyer TD.Transjugulat intrahepatic portosystemic shunt for refractory hepatic hydrothorax:good for the lungs,not so good for the liver[J].Hepatology,1997;26:286A.
  • 7Duvoux C,Zanditenas D,Hezode C,et al.Effects of noradrenalin and albumin in patients with type Ⅰ hepatorenal syndrome:a pilot study[J].Hepatology,2002; 36:374.
  • 8Brensing KA,Textor J,Perz J,et al.Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in nontransplant cirrhotics with hepatorenal syndrome:a phase Ⅱ study[J].Gut,2000; 47:288.
  • 9Guevara M,Gines P,Bandi JC,et al.Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome:effects on renal function and vasoactive systems[J].Hepatology,1998;28;416.
  • 10Perello A,Garcia-Pagan JC,Gilabert R,et al.TIPS is a useful long-term derivative therapy for patients with BuddChiari syndrome uncontrolled by medical therapy[J].Hepatology,2002;35:132.

共引文献441

同被引文献36

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部